Basic Information
RNALocate ID: | RLID:11004240 |
RNA Symbol: | hsa-miR-1228-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-1228 |
RNA ID: | miRBase:MIMAT0005583 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23771658 |
Tissue/Cell Line: | Hepatoma cells |
Method: | Microarray|qRT-PCR |
Description: | In line with the difference in number of detectable miRNAs, the expression levels of these miRNAs also varied between MVs and cells. Statistical analysis of the 148 co-expressing miRNAs showed that 25 miRNAs were aberrantly elevated inMVs and 75 miRNAs were significantly elevated in cells with more than two folds change. Forty-eight miRNAs had the similar signal intensity in both groups (table 1). Data are collected from Table 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11004239 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11001638 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
RLID-D:11004136 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-1228-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-05536 |
MNDR | hsa-miR-1228-3p | B cell lymphoma of malt type | MNDR-E-MI-05537 |
MNDR | hsa-miR-1228-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-05538 |
MNDR | hsa-miR-1228-3p | Lymphoma | MNDR-E-MI-05539 |
MNDR | hsa-miR-1228-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-05540 |
MNDR | hsa-miR-1228-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-05541 |
MNDR | hsa-miR-1228-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-05542 |
MNDR | hsa-miR-1228-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-05543 |
MNDR | hsa-miR-1228-3p | Breast cancer luminal | MNDR-E-MI-05544 |
MNDR | hsa-miR-1228-3p | Dermatomyositis | MNDR-E-MI-05545 |
MNDR | hsa-miR-1228-3p | Prostate cancer | MNDR-E-MI-05546 |
MNDR | hsa-miR-1228-3p | Chronic lymphocytic leukemia | MNDR-E-MI-05547 |
MNDR | hsa-miR-1228-3p | Gastric cancer | MNDR-E-MI-05548 |
MNDR | hsa-miR-1228-3p | Alzheimer disease | MNDR-E-MI-05549 |
MNDR | hsa-miR-1228-3p | Parkinson disease | MNDR-E-MI-05550 |
MNDR | hsa-miR-1228-3p | Basal-like breast cancer | MNDR-E-MI-05551 |
MNDR | hsa-miR-1228-3p | Pancreatic cancer | MNDR-E-MI-05552 |
MNDR | hsa-miR-1228-3p | Nephroblastoma | MNDR-E-MI-05553 |
MNDR | hsa-miR-1228-3p | Colon cancer | MNDR-E-MI-05554 |
MNDR | hsa-miR-1228-3p | Colon adenocarcinoma | MNDR-E-MI-05555 |
MNDR | hsa-miR-1228-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-05556 |
MNDR | hsa-miR-1228-3p | Carcinoma ductal breast | MNDR-E-MI-05557 |
MNDR | hsa-miR-1228-3p | Glioblastoma | MNDR-E-MI-05558 |
MNDR | hsa-miR-1228-3p | Malignant glioma | MNDR-E-MI-05559 |
MNDR | hsa-miR-1228-3p | Osteosarcoma | MNDR-E-MI-05560 |
MNDR | hsa-miR-1228-3p | Liver cancer | MNDR-E-MI-05561 |
MNDR | hsa-miR-1228-3p | Carcinoma lung non-small-cell | MNDR-E-MI-05562 |
MNDR | hsa-miR-1228-3p | Lung adenocarcinoma | MNDR-E-MI-05563 |
MNDR | hsa-miR-1228-3p | Adrenocortical cancer | MNDR-E-MI-05564 |
MNDR | hsa-miR-1228-3p | Thyroid carcinoma | MNDR-E-MI-05565 |
MNDR | hsa-miR-1228-3p | Ovarian carcinoma | MNDR-E-MI-05566 |
MNDR | hsa-miR-1228-3p | Bladder urothelial carcinoma | MNDR-E-MI-05567 |
MNDR | hsa-miR-1228-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-05568 |
MNDR | hsa-miR-1228-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-05569 |
MNDR | hsa-miR-1228-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-05570 |
MNDR | hsa-miR-1228-3p | Biliary tract cancer | MNDR-E-MI-05571 |
MNDR | hsa-miR-1228-3p | Cholangiocarcinoma | MNDR-E-MI-05572 |
MNDR | hsa-miR-1228-3p | Esophageal cancer | MNDR-E-MI-05573 |
MNDR | hsa-miR-1228-3p | T acute lymphoblastic leukemia | MNDR-E-MI-05574 |
MNDR | hsa-miR-1228-3p | Acute t cell leukemia | MNDR-E-MI-05575 |
MNDR | hsa-miR-1228-3p | Adenoma | MNDR-E-MI-05576 |
MNDR | hsa-miR-1228-3p | Breast invasive carcinoma | MNDR-E-MI-05577 |
MNDR | hsa-miR-1228-3p | Hepatocellular carcinoma | MNDR-E-MI-05578 |
MNDR | hsa-miR-1228-3p | B-cell lymphoma | MNDR-E-MI-05579 |
MNDR | hsa-miR-1228-3p | Colorectal cancer | MNDR-E-MI-05580 |
MNDR | hsa-miR-1228-3p | Nasopharynx carcinoma | MNDR-E-MI-05581 |
MNDR | hsa-miR-1228-3p | Tyrosinemias | MNDR-E-MI-05582 |
MNDR | hsa-miR-1228-3p | Multiple myeloma | MNDR-E-MI-05583 |
MNDR | hsa-miR-1228-3p | Nasopharyngeal cancer | MNDR-E-MI-05584 |
MNDR | hsa-miR-1228-3p | Tubulovillous adenoma | MNDR-E-MI-05585 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BMP2K | Homo sapiens | RR00226777 |
TOP